A detailed history of Evermay Wealth Management LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Evermay Wealth Management LLC holds 4,040 shares of LLY stock, worth $3.19 Million. This represents 0.58% of its overall portfolio holdings.

Number of Shares
4,040
Previous 4,073 0.81%
Holding current value
$3.19 Million
Previous $3.69 Million 2.93%
% of portfolio
0.58%
Previous 0.59%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 25, 2024

SELL
$772.14 - $960.02 $25,480 - $31,680
-33 Reduced 0.81%
4,040 $3.58 Million
Q2 2024

Aug 01, 2024

SELL
$724.87 - $909.04 $79,735 - $99,994
-110 Reduced 2.63%
4,073 $3.69 Million
Q1 2024

May 13, 2024

SELL
$592.2 - $792.28 $62,181 - $83,189
-105 Reduced 2.45%
4,183 $3.25 Million
Q4 2023

Feb 09, 2024

BUY
$525.19 - $619.13 $347,150 - $409,244
661 Added 18.22%
4,288 $2.5 Million
Q3 2023

Nov 13, 2023

BUY
$434.7 - $599.3 $31,733 - $43,748
73 Added 2.05%
3,627 $1.95 Million
Q2 2023

Aug 10, 2023

SELL
$350.74 - $468.98 $137,490 - $183,840
-392 Reduced 9.93%
3,554 $1.67 Million
Q1 2023

May 15, 2023

BUY
$310.63 - $364.82 $66,164 - $77,706
213 Added 5.71%
3,946 $1.36 Million
Q4 2022

Jan 19, 2023

BUY
$321.55 - $374.67 $57,879 - $67,440
180 Added 5.07%
3,733 $0
Q3 2022

Nov 14, 2022

BUY
$296.48 - $337.87 $4,743 - $5,405
16 Added 0.45%
3,553 $1.15 Million
Q2 2022

Aug 15, 2022

BUY
$278.73 - $327.27 $119,853 - $140,726
430 Added 13.84%
3,537 $1.15 Million
Q1 2022

May 16, 2022

SELL
$234.69 - $291.66 $86,365 - $107,330
-368 Reduced 10.59%
3,107 $890,000
Q4 2021

Feb 14, 2022

SELL
$224.85 - $279.04 $4,721 - $5,859
-21 Reduced 0.6%
3,475 $960,000
Q3 2021

Nov 12, 2021

SELL
$221.6 - $272.71 $32,575 - $40,088
-147 Reduced 4.04%
3,496 $808,000
Q2 2021

Aug 13, 2021

SELL
$180.55 - $233.54 $21,666 - $28,024
-120 Reduced 3.19%
3,643 $836,000
Q1 2021

May 10, 2021

SELL
$164.32 - $212.72 $4,108 - $5,318
-25 Reduced 0.66%
3,763 $703,000
Q4 2020

Feb 16, 2021

BUY
$130.46 - $172.63 $25,048 - $33,144
192 Added 5.34%
3,788 $640,000
Q2 2020

Jul 20, 2020

SELL
$136.42 - $164.18 $40,925 - $49,254
-300 Reduced 7.7%
3,596 $590,000
Q1 2020

Apr 24, 2020

SELL
$119.05 - $147.35 $9,643 - $11,935
-81 Reduced 2.04%
3,896 $540,000
Q4 2019

Feb 11, 2020

BUY
$106.92 - $132.43 $98,794 - $122,365
924 Added 30.27%
3,977 $523,000
Q3 2019

Oct 29, 2019

SELL
$106.79 - $116.16 $2,883 - $3,136
-27 Reduced 0.88%
3,053 $341,000
Q2 2019

Jul 23, 2019

BUY
$110.79 - $129.32 $7,976 - $9,311
72 Added 2.39%
3,080 $341,000
Q1 2019

May 03, 2019

SELL
$111.31 - $131.02 $6,455 - $7,599
-58 Reduced 1.89%
3,008 $390,000
Q4 2018

Jan 24, 2019

BUY
$105.9 - $118.64 $118,184 - $132,402
1,116 Added 57.23%
3,066 $355,000
Q3 2018

Oct 29, 2018

BUY
$85.86 - $107.31 $167,427 - $209,254
1,950 New
1,950 $209,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $750B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Evermay Wealth Management LLC Portfolio

Follow Evermay Wealth Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Evermay Wealth Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Evermay Wealth Management LLC with notifications on news.